DYN Dyne Therapeutics
- 26.250
- +0.170+0.65%
- 25.750
- -0.500-1.90%
Dyne Therapeutics News
Dyne Therapeutics | 10-Q: Quarterly report
Dyne Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Dyne Therapeutics | 8-K: Dyne Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
Dyne Therapeutics | ARS: Annual Report to Security Holders
Dyne Therapeutics | DEFA14A: Others
Dyne Therapeutics | DEF 14A: Definitive information statements
Dyne Therapeutics | 3/A: Initial statement of beneficial ownership of securities (Amendment)-Officer Cox John
Dyne Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer McNeill Jonathan
Dyne Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-RA Capital Management, L.P.(6.4%),Peter Kolchinsky(6.4%), etc.
Dyne Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Dyne Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Cox John
Dyne Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Cox John
Dyne Therapeutics | 8-K: Current report
Dyne Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer HIGH SUSANNA GATTI
Dyne Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer McNeill Jonathan
Dyne Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Scalzo Richard William
Dyne Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Farwell Wildon
Dyne Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Brumm Joshua T
Dyne Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Beskrovnaya Oxana
Dyne Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Analysis
Price Target
No Data
